Episodes
Friday Mar 17, 2023
Complex Patient Case 2 - Managing Adverse Effects
Friday Mar 17, 2023
Friday Mar 17, 2023
Reason for Visit: The patient is here today for hypotension and diabetes follow-up. The primary care physician has consulted the clinical pharmacist regarding hypotension.
Chief Complaint: “I feel dizzy when I stand up and feel like my heart is racing. I have never passed out, but it feels like I might, and I usually have to sit back down."
Guest Authors: Kellie Ball, PharmD and Johnathon Proctor, PharmD
Expert Panelists: Morgan Weaver Godfrey, PharmD, BCPS and Richard J. Silvia, PharmD, BCPP
Friday Mar 03, 2023
Preventing Autoimmune Disease: Can Supplements Get the Job Done?
Friday Mar 03, 2023
Friday Mar 03, 2023
Currently, there are no known safe, effective, and inexpensive ways that can prevent or reduce the risk of developing autoimmune diseases. Any strategy that could reduce the chances of developing an autoimmune disorder would be welcomed by practitioners and patients alike. Perhaps vitamin D and omega 3 fatty acid supplementation can get the job done.
Guest Authors: Rileigh Provenza, PharmD and Nicole Slater, PharmD, BCACP
Music by Good Talk
Saturday Feb 18, 2023
Top Ten Things Every Clinician Should Know About Treating Obesity
Saturday Feb 18, 2023
Saturday Feb 18, 2023
Obesity is a chronic, progressive, multi-factorial, neurobehavioral disease characterized by excessive adipose tissue. Here are some things every clinician should know about treating overweight and obesity but be sure to read the written commentary posted on iForumRx.org
Guest Authors: Jennifer N. Clements, PharmD, BCPS, BCACP, CDCES, BC-ADM and Seena L. Haines, PharmD., BCACP, NBC-HWC, CHWC
Music by Good Talk
Friday Feb 03, 2023
Friday Feb 03, 2023
Hyperkalemia is a common electrolyte disorder in patients with CKD that can be exacerbated by renin-angiotensin-aldosterone system (RAAS) inhibitors. While hyperkalemia poses potential risks to patients with CKD, the potentially negative impact of discontinuing RAAS inhibitor therapy on long-term renal and cardiovascular outcomes in CKD patients is unclear.
Guest Author: Michelle A. Fravel, PharmD, BCPS
Music by Good Talk
Friday Jan 20, 2023
Complex Patient Case - Women’s Health + Contraception
Friday Jan 20, 2023
Friday Jan 20, 2023
Reason for Visit: JS was referred by her PCP to the ambulatory care pharmacist for contraceptive counseling.
Chief Complaint: “I think I’m leaning more towards the pill, but I’m really open to anything. It’s also itchy again down there, probably another yeast infection.”
Guest Author: Elizabeth Salisbury, PharmD
Expert Panelists: Ashley Meredith, PharmD, MPH, BCACP; Rebecca Stone, PharmD, BCACP, and Sally Rafie, PharmD, BCPS
Wanna earn continuing pharmacy education (CPE) for this program? Be sure to log-in to the iForumRx website, review the case, listen to the podcast, and scroll to the bottom of the page to claim CE.
Check out the Birth Control Pharmacist website.
--------
Friday Jan 06, 2023
Top Ten Podcasts Every Ambulatory Care Clinician Should Know About
Friday Jan 06, 2023
Friday Jan 06, 2023
What is the secret to staying up to date with clinical updates, tips for flourishing in your practice and life, and inspirational stories about pharmacist entrepreneurs…all at the click of a button? No, it is not magic. It is a podcast!
Guest Authors: Elizabeth Yett, PharmD, BCACP, TTS and Elizabeth Hearn, PharmD, BCACP
Music by Good Talk
Monday Dec 26, 2022
The Generic Levothyroxine Conundrum
Monday Dec 26, 2022
Monday Dec 26, 2022
Would you be willing to pay three times more for a brand-name levothyroxine product than a generic equivalent? Clinical practice guidelines recommend against switching between products. As a result, levothyroxine has higher brand-name product dispensing rates than other medications, costing patients and the healthcare system much more money.
Guest Authors: Connie Liang, PharmD and Kathleen Pincus, PharmD, BCPS, BCACP
Music by Good Talk
Friday Dec 09, 2022
Is Icosapent Ethyl a QALY-ty Investment?
Friday Dec 09, 2022
Friday Dec 09, 2022
The landmark REDUCE-IT trial demonstrated that icosapent ethyl (IPE) 4 g daily significantly reduced cardiovascular events in high-risk patients when added to statin therapy, but is a fancy fish oil supplement really worth our coin?
Guest Authors: Joseph Nardolillo, PharmD, BCACP and Vivian Cheng, PharmD, BCPS, BCACP
Music by Good Talk
Monday Nov 28, 2022
Level Up! An Abstinence Game for Smoking Cessation
Monday Nov 28, 2022
Monday Nov 28, 2022
Smoking remains a habit for many people, even among those who are motivated to quit. Historically, most smoking cessation interventions have targeted individuals who are ready to quit smoking in the next 30 days, overlooking those who are not yet ready to quit. Perhaps an abstinence game, Take a Break, can move people in pre-contemplation and contemplation toward quitting.
Guest Authors: Anna Rhett, PharmD and Ha K. Pham, PharmD, BCACP
Music by Good Talk
Friday Nov 11, 2022
Breaking the SABA-only Rescue Habit: Two Drugs Are Better Than One
Friday Nov 11, 2022
Friday Nov 11, 2022
It is well established that overuse of short-acting beta-agonists (SABA) increases the risk of poor asthma control, exacerbations, and increased mortality. Several studies have combined a beta-agonist with an inhaled corticosteroid (ICS). The combination provides symptom relief and decreases the risk of poor outcomes. The days of using albuterol monotherapy should be coming to an end; two drugs are better than one!
Guest Authors: Katherine Montag Schafer, PharmD, BCACP, CDCES and Stefanie C. Nigro, PharmD, BCACP, CDCES
Music by Good Talk